Search research articles
Contact Us
Filters
Showing results (71-80 of 185) with videos related to
Page
of 19
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
June 21, 2016
Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET
I Bahce, M Yaqub, E F Smit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule
H J Groen, E Fokkema, B Biesma, et al.
European Journal of Nuclear Medicine
|
July 20, 2000
Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods
C J Hoekstra, I Paglianiti, O S Hoekstra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?
C Dickhoff, K J Hartemink, J Kooij, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 4, 2018
Variability and Repeatability of Quantitative Uptake Metrics in <sup>18</sup>F-FDG PET/CT of Non-Small Cell Lung Cancer: Impact of Segmentation Method, Uptake Interval, and Reconstruction Protocol
Mingzan Zhuang, David Vállez García, Gerbrand M Kramer, et al.
British Journal of Cancer
|
January 1, 1997
A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood
W Helfrich, R ten Poele, G J Meersma, et al.
The Netherlands Journal of Medicine
|
June 21, 2002
Failure patterns of combined modality treatment in lung cancer: the impact of staging
C J Hoekstra, H Rijna, E F Smit, et al.
EJNMMI Research
|
February 5, 2019
Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics
M C F Cysouw, S V S Golla, V Frings, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 26, 2011
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment
A Becker, L Crombag, D A M Heideman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2001
Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer
J W van Putten, T Kerbush, E F Smit, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 185) with videos related to
Sort By:
Page
of 19
Lung Cancer (Amsterdam, Netherlands)
|
June 21, 2016
Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET
I Bahce, M Yaqub, E F Smit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule
H J Groen, E Fokkema, B Biesma, et al.
European Journal of Nuclear Medicine
|
July 20, 2000
Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods
C J Hoekstra, I Paglianiti, O S Hoekstra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?
C Dickhoff, K J Hartemink, J Kooij, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 4, 2018
Variability and Repeatability of Quantitative Uptake Metrics in <sup>18</sup>F-FDG PET/CT of Non-Small Cell Lung Cancer: Impact of Segmentation Method, Uptake Interval, and Reconstruction Protocol
Mingzan Zhuang, David Vállez García, Gerbrand M Kramer, et al.
British Journal of Cancer
|
January 1, 1997
A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood
W Helfrich, R ten Poele, G J Meersma, et al.
The Netherlands Journal of Medicine
|
June 21, 2002
Failure patterns of combined modality treatment in lung cancer: the impact of staging
C J Hoekstra, H Rijna, E F Smit, et al.
EJNMMI Research
|
February 5, 2019
Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics
M C F Cysouw, S V S Golla, V Frings, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 26, 2011
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment
A Becker, L Crombag, D A M Heideman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2001
Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer
J W van Putten, T Kerbush, E F Smit, et al.
Page
of 19